257 related articles for article (PubMed ID: 35247887)
1. Ketogenesis Attenuates KLF5-Dependent Production of CXCL12 to Overcome the Immunosuppressive Tumor Microenvironment in Colorectal Cancer.
Wei R; Zhou Y; Li C; Rychahou P; Zhang S; Titlow WB; Bauman G; Wu Y; Liu J; Wang C; Weiss HL; Evers BM; Wang Q
Cancer Res; 2022 Apr; 82(8):1575-1588. PubMed ID: 35247887
[TBL] [Abstract][Full Text] [Related]
2. KLF5 inhibition potentiates anti-PD1 efficacy by enhancing CD8
Wu Q; Liu Z; Gao Z; Luo Y; Li F; Yang C; Wang T; Meng X; Chen H; Li J; Kong Y; Dong C; Sun S; Chen C
Theranostics; 2023; 13(4):1381-1400. PubMed ID: 36923542
[No Abstract] [Full Text] [Related]
3. Restored Ketosis Drives Anticancer Immunity in Colorectal Cancer.
Montrose DC; Galluzzi L
Cancer Res; 2022 Apr; 82(8):1464-1466. PubMed ID: 35425965
[TBL] [Abstract][Full Text] [Related]
4. Cancer-associated fibroblasts-derived CXCL12 enhances immune escape of bladder cancer through inhibiting P62-mediated autophagic degradation of PDL1.
Zhang Z; Yu Y; Zhang Z; Li D; Liang Z; Wang L; Chen Y; Liang Y; Niu H
J Exp Clin Cancer Res; 2023 Nov; 42(1):316. PubMed ID: 38001512
[TBL] [Abstract][Full Text] [Related]
5. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
Eskandari-Malayeri F; Rezaei M
Front Immunol; 2022; 13():996145. PubMed ID: 36275750
[TBL] [Abstract][Full Text] [Related]
6. Co-Delivery Nanomicelles for Potentiating TNBC Immunotherapy by Synergetically Reshaping CAFs-Mediated Tumor Stroma and Reprogramming Immunosuppressive Microenvironment.
Zhang Y; Han X; Wang K; Liu D; Ding X; Hu Z; Wang J
Int J Nanomedicine; 2023; 18():4329-4346. PubMed ID: 37545872
[TBL] [Abstract][Full Text] [Related]
7. Local Blockade of Interleukin 10 and C-X-C Motif Chemokine Ligand 12 with Nano-Delivery Promotes Antitumor Response in Murine Cancers.
Shen L; Li J; Liu Q; Song W; Zhang X; Tiruthani K; Hu H; Das M; Goodwin TJ; Liu R; Huang L
ACS Nano; 2018 Oct; 12(10):9830-9841. PubMed ID: 30253648
[TBL] [Abstract][Full Text] [Related]
8. Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis.
Paauwe M; Schoonderwoerd MJA; Helderman RFCP; Harryvan TJ; Groenewoud A; van Pelt GW; Bor R; Hemmer DM; Versteeg HH; Snaar-Jagalska BE; Theuer CP; Hardwick JCH; Sier CFM; Ten Dijke P; Hawinkels LJAC
Clin Cancer Res; 2018 Dec; 24(24):6331-6344. PubMed ID: 29945992
[TBL] [Abstract][Full Text] [Related]
9. CXCR4 receptor blockage reduces the contribution of tumor and stromal cells to the metastatic growth in the liver.
Benedicto A; Romayor I; Arteta B
Oncol Rep; 2018 Apr; 39(4):2022-2030. PubMed ID: 29436696
[TBL] [Abstract][Full Text] [Related]
10. Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1
Gok Yavuz B; Gunaydin G; Gedik ME; Kosemehmetoglu K; Karakoc D; Ozgur F; Guc D
Sci Rep; 2019 Feb; 9(1):3172. PubMed ID: 30816272
[TBL] [Abstract][Full Text] [Related]
11. CXCL12 Signaling in the Tumor Microenvironment.
Portella L; Bello AM; Scala S
Adv Exp Med Biol; 2021; 1302():51-70. PubMed ID: 34286441
[TBL] [Abstract][Full Text] [Related]
12. Carcinoma associated fibroblasts (CAFs) promote breast cancer motility by suppressing mammalian Diaphanous-related formin-2 (mDia2).
Dvorak KM; Pettee KM; Rubinic-Minotti K; Su R; Nestor-Kalinoski A; Eisenmann KM
PLoS One; 2018; 13(3):e0195278. PubMed ID: 29596520
[TBL] [Abstract][Full Text] [Related]
13. Crosstalk between cancer-associated fibroblasts and immune cells in peritoneal metastasis: inhibition in the migration of M2 macrophages and mast cells by Tranilast.
Nakamura Y; Kinoshita J; Yamaguchi T; Aoki T; Saito H; Hamabe-Horiike T; Harada S; Nomura S; Inaki N; Fushida S
Gastric Cancer; 2022 May; 25(3):515-526. PubMed ID: 34997450
[TBL] [Abstract][Full Text] [Related]
14. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
15. Increasing Tumor-Infiltrating T Cells through Inhibition of CXCL12 with NOX-A12 Synergizes with PD-1 Blockade.
Zboralski D; Hoehlig K; Eulberg D; Frömming A; Vater A
Cancer Immunol Res; 2017 Nov; 5(11):950-956. PubMed ID: 28963140
[TBL] [Abstract][Full Text] [Related]
16. Tumor microenvironment reprogramming combined with immunogenic enhancement by nanoemulsions potentiates immunotherapy.
Shen W; Li Y; Yang Z; Li W; Cao Y; Liu Y; Wang Z; Pei R; Xing C
J Nanobiotechnology; 2024 Apr; 22(1):154. PubMed ID: 38581017
[TBL] [Abstract][Full Text] [Related]
17. Cancer-Associated Fibroblasts Affect Intratumoral CD8
Kato T; Noma K; Ohara T; Kashima H; Katsura Y; Sato H; Komoto S; Katsube R; Ninomiya T; Tazawa H; Shirakawa Y; Fujiwara T
Clin Cancer Res; 2018 Oct; 24(19):4820-4833. PubMed ID: 29921731
[No Abstract] [Full Text] [Related]
18. Dissecting tumor microenvironment heterogeneity in syngeneic mouse models: insights on cancer-associated fibroblast phenotypes shaped by infiltrating T cells.
Carretta M; Thorseth ML; Schina A; Agardy DA; Johansen AZ; Baker KJ; Khan S; Rømer AMA; Fjæstad KY; Linder H; Kuczek DE; Donia M; Grøntved L; Madsen DH
Front Immunol; 2023; 14():1320614. PubMed ID: 38259467
[TBL] [Abstract][Full Text] [Related]
19. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
Hu S; Ma J; Su C; Chen Y; Shu Y; Qi Z; Zhang B; Shi G; Zhang Y; Zhang Y; Huang A; Kuang Y; Cheng P
Acta Biomater; 2021 Nov; 135():567-581. PubMed ID: 34506976
[TBL] [Abstract][Full Text] [Related]
20. Targeting cancer-associated fibroblast-secreted WNT2 restores dendritic cell-mediated antitumour immunity.
Huang TX; Tan XY; Huang HS; Li YT; Liu BL; Liu KS; Chen X; Chen Z; Guan XY; Zou C; Fu L
Gut; 2022 Feb; 71(2):333-344. PubMed ID: 33692094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]